title: Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems.
authors.affiliation: Department of Neuroscience and Behavioral Science, University of Sao Paulo (USP) - Ribeirao Preto, SP, CEP 14048-900, Brazil. Electronic address: j.p@usp.br.
authors.forename: Joao Paulo
authors.initials: JP
authors.lastname: Maia-de-Oliveira
authors.affiliation: Department of Biophysics Pharmacology, Federal University of Rio Grande do Norte (UFRN), Natal, RN CEP 59012420, Brazil.
authors.forename: Bruno
authors.initials: B
authors.lastname: Lobão-Soares
authors.affiliation: Neurochemical Research Unit, Department of Psychiatry, University of Alberta, 12-105B CSB, Edmonton, AB T6G 2G3, Canada.
authors.forename: Glen B
authors.initials: GB
authors.lastname: Baker
authors.affiliation: Neurochemical Research Unit, Department of Psychiatry, University of Alberta, 12-105B CSB, Edmonton, AB T6G 2G3, Canada.
authors.forename: Serdar M
authors.initials: SM
authors.lastname: Dursun
authors.affiliation: Department of Neuroscience and Behavioral Science, University of Sao Paulo (USP) - Ribeirao Preto, SP, CEP 14048-900, Brazil.
authors.forename: Jaime E C
authors.initials: JE
authors.lastname: Hallak
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D004359:Drug Therapy, Combination; D006801:Humans; D020030:Nitric Oxide Donors / Q000008:administration & dosage / Q000494:pharmacology*; D009599:Nitroprusside / Q000008:administration & dosage / Q000494:pharmacology*; D012559:Schizophrenia / Q000188:drug therapy*; D009435:Synaptic Transmission / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D020030:Nitric Oxide Donors; D009599:Nitroprusside; D004298:Dopamine